Hkg Stock MovementKejia Pharmaceuticals-B (02171.HK) surged over 4% after CT0596 received IND approval from the National Medical Products Administration for the treatment of R/R MM patients.
According to Zhituo Finance APP, Kexin Pharmaceutical-B (02171.HK) has risen over 4%, currently up 4.53% at HKD 13.39, with a trading volume of HKD 8.1968 million.
Latest
